日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer.

MEN1 通过破坏 CD44 选择性剪接促进铁死亡,从而抑制肺癌。

Pan Ting, Zhu Jiamei, Wang Xuyan, Tang Dekun, Wang Ziming, Yang Yunqiao, Teng Yin, Tian Qianting, Dan Guixue, Chen Chaochun, Yu Dafang, Liu Mengyuan, Wang Houmei, Zhang Tuo, Guo Bing, Chen Tengxiang, Jin Bangming

IGF-1 Deficiency Serves as an Integrated Biomarker Pathogenic Driver and Predictor in Poor Ovarian Response.

IGF-1 缺乏症可作为卵巢反应不良的综合生物标志物致病驱动因素和预测因子。

Hu Zhu, Yu Yuanyuan, Huang Guanyou, Li Jinnan, Yang Chao, Long Aizhuan, Tang Jia, Chen Tengxiang, Zhao Shuyun, Zhang Tuo

Correction: CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer

更正:CXCL8 调节 M0 巨噬细胞的增殖和极化,从而影响宫颈癌的肿瘤进展。

Zhao, Xiyan; Yang, Li; Pan, Jigang; Zeng, Zhirui; Zhang, Tuo; Yang, Yushi; Zhang, Jingjing; Chen, Tengxiang; Xiao, Ziwen; Pan, Wei

Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure.

利用工程化DFO纳米颗粒靶向颗粒细胞治疗化疗引起的卵巢早衰

Zhang Tuo, Sheng Zhiyi, Zhang Jixian, Zhang Heng, Zhang Yan, Du Yunpeng, Liu Xiangxin, Hu Zhu, Luo Qiyuan, Xu Guoqiang, Gao Yuan, He Meina, Chen Tengxiang

Whole-gene CRISPR/cas9 library screen revealed targeting STAT6 increased the sensitivity of liver cancer to celecoxib via inhibiting arachidonic acid shunting.

全基因 CRISPR/Cas9 文库筛选显示,靶向 STAT6 可通过抑制花生四烯酸分流来提高肝癌对塞来昔布的敏感性

Hu Chujiao, Zeng Zhirui, Bao Xin, Li Dahuan, Tai Huading, Zeng Haohao, Luo Cheng, Tang Lei, Chen Tengxiang, Zuo Shi

Synergistic blood-based diagnostic value of AP3B1 and BMPR2 in Parkinson's disease.

AP3B1 和 BMPR2 在帕金森病中具有协同的血液诊断价值。

Zhao Xiyan, Yang Li, Luan Yumin, Ding Tao, Yang Xinglong, Geng Xin, Zhang Tuo, Pan Jigang, Xiao Ziwen, Pan Wei, Chen Tengxiang

MRO/HNRNPU/CCL5 feedback loop amplifies M2 macrophage and breast cancer cell crosstalk to drive progression.

MRO/HNRNPU/CCL5 反馈回路增强 M2 巨噬细胞和乳腺癌细胞之间的相互作用,从而推动疾病进展

Zeng Zhirui, Bao Xin, Lei Shan, Tang Wenjing, Tai Huading, Wang Lu, Li Dahuan, Liu Shu, Chen Tengxiang

Identification of the clinical value and biological effects of TTN mutation in liver cancer.

确定 TTN 突变在肝癌中的临床价值和生物学效应

Zhang Zhixue, Sun Yating, Zeng Zhirui, Li Dahuan, Cao Wenpeng, Lei Shan, Chen Tengxiang

Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy.

以 DiosMetin 7-O-β-D-葡糖醛酸苷靶向 INF2:结直肠癌治疗的新策略

Zeng Zhirui, Ke Yun, Huang Fei, Li Hangyi, Zhang Xiaomin, Li Dahuan, Wu Yingmin, Chen Tengxiang, Zhen Yunhuan

Bioinformatics Combined With Biological Experiments to Identify the Pathogenetic Link of Type 2 Diabetes for Breast Cancer.

生物信息学与生物学实验相结合,揭示2型糖尿病与乳腺癌的致病联系

Bao Xin, Zeng Zhirui, Tang Wenjing, Li Dahuan, Fan Xianrui, Chen Kang, Wang Yongkang, Ai Weijie, Yang Qian, Liu Shu, Chen Tengxiang